Learn More
Medchemexpress LLC DAMGO TFA | 950492-85-0 | 99.5% | 627.61 | 25 MG

Supplier: Medchemexpress LLC 25MGHYP0210B
DAMGO TFA is a selective agonist for the μ-opioid receptor (μ-OPR) with a Kd of 3.46 nM for native μ-OPR. It significantly reduces the activation of neuronal Akt and ERK1/2 by CXCL12 and inhibits CXCL12-promoted neuronal survival, without down-regulating CXCR4 protein expression. It is for research use only.
- Effectively inhibits prostaglandin E2 (PGE2) induced increase in a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R INa).
- Produces significant anti-injury effects.
- Exhibits long-lasting analgesic effects in a dose-dependent manner.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.